Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melatonin: Clinical Perspectives in Neurodegeneration
Daniel P. Cardinali
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 165

Showing 1-25 of 165 citing articles:

Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease
Diana Maria Chiţimuș, M Popescu, Suzana Elena Voiculescu, et al.
Biomolecules (2020) Vol. 10, Iss. 9, pp. 1211-1211
Open Access | Times Cited: 241
Importance of Melatonin in Assisted Reproductive Technology and Ovarian Aging
Hiroshi Tamura, Mai Jozaki, Manabu Tanabe, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1135-1135
Open Access | Times Cited: 186
Melatonin inhibits cytosolic mitochondrial DNA–induced neuroinflammatory signaling in accelerated aging and neurodegeneration
Abhishek Jauhari, Sergei V. Baranov, Yalikun Suofu, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 6, pp. 3124-3136
Open Access | Times Cited: 158
Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases
Dongmei Chen, Tao Zhang, Tae Ho Lee
Biomolecules (2020) Vol. 10, Iss. 8, pp. 1158-1158
Open Access | Times Cited: 108
Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer’s disease and insomnia: A systematic review and meta-analysis of randomized controlled trials
Dewan Md. Sumsuzzman, Jeong‐Hyun Choi, Yunho Jin, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 459-473
Open Access | Times Cited: 89
Safety of higher doses of melatonin in adults: A systematic review and meta‐analysis
Zoe Menczel Schrire, Craig L. Phillips, Julia L. Chapman, et al.
Journal of Pineal Research (2021) Vol. 72, Iss. 2
Open Access | Times Cited: 80
Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
Daniel P. Cardinali, Gregory M. Brown, Seithikurippu R. Pandi‐Perumal
Diseases (2020) Vol. 8, Iss. 4, pp. 44-44
Open Access | Times Cited: 79
Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer's disease
Miguel A. Pappolla, George Perry, Xiang Fang, et al.
Neurobiology of Disease (2021) Vol. 156, pp. 105403-105403
Open Access | Times Cited: 75
Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases
Serena Stanga, Anna Caretto, Marina Boido, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3719-3719
Open Access | Times Cited: 74
Emerging role of the Hippo pathway in autophagy
Dongying Wang, Jiaxing He, Bingyu Huang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 10
Open Access | Times Cited: 71
Melatonin’s neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders
Lindsay Melhuish Beaupre, Gregory M. Brown, Vanessa F. Gonçalves, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 71
Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry
Gerwyn Morris, Adam J. Walker, Ken Walder, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 5, pp. 2158-2182
Closed Access | Times Cited: 61
Insomnia, sleep loss, and circadian sleep disturbances in mood disorders: a pathway toward neurodegeneration and neuroprogression? A theoretical review
Laura Palagini, Pierre A. Geoffroy, Mario Miniati, et al.
CNS Spectrums (2021) Vol. 27, Iss. 3, pp. 298-308
Open Access | Times Cited: 57
Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action
Ana Muñoz-Jurado, Begoña M. Escribano, Javier Caballero‐Villarraso, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1569-1596
Open Access | Times Cited: 57
Melatonin as the Cornerstone of Neuroimmunoendocrinology
I. М. Kvetnoy, Dmitry O. Ivanov, Ekaterina Mironova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1835-1835
Open Access | Times Cited: 53
Redox Biology of Melatonin: Discriminating Between Circadian and Noncircadian Functions
Rüdiger Hardeland
Antioxidants and Redox Signaling (2022) Vol. 37, Iss. 10-12, pp. 704-725
Open Access | Times Cited: 45
Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Douglas M. Lopes, Sophie K. Llewellyn, Ian F. Harrison
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 44
Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases
Virna Margarita Martín Giménez, Natalia de las Heras, Vicente Lahera, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 41
Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer’s disease
Dongmei Chen, Guihua Lan, Ruomeng Li, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults
Colin Tuft, Elie Matar, Zoe Menczel Schrire, et al.
Clinical Interventions in Aging (2023) Vol. Volume 18, pp. 49-59
Open Access | Times Cited: 27
The Vital Role of Melatonin and Its Metabolites in the Neuroprotection and Retardation of Brain Aging
Georgeta Bocheva, Dimitar Bakalov, Petar Iliev, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5122-5122
Open Access | Times Cited: 14
Melatonin in cancer biology: pathways, derivatives, and the promise of targeted delivery
Yu-juan Yi, Hong Tang, Peng-lai Pi, et al.
Drug Metabolism Reviews (2024) Vol. 56, Iss. 1, pp. 62-79
Closed Access | Times Cited: 9
Natural Compounds for Preventing Age-Related Diseases and Cancers
Mi‐Ran Ki, Sol Youn, Dong Hyun Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7530-7530
Open Access | Times Cited: 8
Wearables in Chronomedicine and Interpretation of Circadian Health
Denis Gubin, Dietmar Weinert, Oliver Stefani, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 327-327
Open Access | Times Cited: 1
Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19
Dun‐Xian Tan, Rüdiger Hardeland
Molecules (2020) Vol. 25, Iss. 19, pp. 4410-4410
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top